Peregrine Pharmaceuticals (PPHM) Announces Significant Progress in Advancing Its Cotara Program Into a Pivotal Phase III Trial
Go back to Peregrine Pharmaceuticals (PPHM) Announces Significant Progress in Advancing Its Cotara Program Into a Pivotal Phase III Trial| PEREGRINE PHARMA (NASDAQ: PPHM) | Delayed: 0.61 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.61 | 52 Week High | $1.33 | |||
| Open | $13.94 | 52 Week Low | $0.29 | |||
| Day High | $0.61 | P/E | N/A | |||
| Day Low | $0.61 | EPS | $-0.50 | |||
| Volume | 660 | |||||
